Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas Trieselmann is active.

Publication


Featured researches published by Thomas Trieselmann.


Bioorganic & Medicinal Chemistry Letters | 2008

Synthesis and SAR studies of indole-based MK2 inhibitors

Zhaoming Xiong; Donghong Amy Gao; Derek Cogan; Daniel R. Goldberg; Ming-Hong Hao; Neil Moss; Edward Pack; Chris Pargellis; Donna Skow; Thomas Trieselmann; Brian Werneburg; Andre White

Chemistry has been developed to specifically functionalize two structurally similar classes of indole-based MK2 inhibitors at positions prompted by a combination of X-ray crystallographic and computer assisted drug design. A gain in molecular potency was obtained by introducing aminomethyl groups to the lactam rings of 6-arylcarbamoyl-tetrahydro-beta-carbolinone and 6-arylcarbamoyl-dihydropyrazino[1,2-a]indolone MK2 inhibitors. In addition, improvements in molecular potency were achieved by expansion of the lactam from a 6- to 7-membered ring leading to 7-arylcarbamoyl-tetrahydro-[1,4]diazepino[1,2-a]indolones.


Archive | 2008

Ccr2 receptor antagonists and uses thereof

Heiner Ebel; Sara Frattini; Kai Gerlach; Riccardo Giovannini; Christoph Hoenke; Rocco Mazzaferro; Marco Santagostino; Stefan Scheuerer; Christofer S. Tautermann; Thomas Trieselmann


Archive | 2009

Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd

Heiner Ebel; Sara Frattini; Riccardo Giovannini; Christoph Hoenke; Thomas Trieselmann; Patrick Tielmann; Stefan Scheuerer; Silke Hobbie; Frank Buettner


Journal of Medicinal Chemistry | 2014

Potent cholesteryl ester transfer protein inhibitors of reduced lipophilicity: 1,1'-spiro-substituted hexahydrofuroquinoline derivatives.

Thomas Trieselmann; Holger Wagner; Klaus Fuchs; Dieter Hamprecht; Daniela Berta; Paolo Cremonesi; Rüdiger Streicher; Gerd Luippold; Astrid Volz; Michael Markert; Herbert Nar


Archive | 2003

Use of substituted 2-phenylbenzimidazoles as medicaments

Ruediger Streicher; Juergen Mack; Rainer Walter; Ingo Konetzki; Thomas Trieselmann; Volkhard Austel


Archive | 2003

Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists

Thomas Trieselmann; Bradford S. Hamilton; Dirk Stenkamp; Stephan Georg Mueller


Archive | 2010

Novel antagonists for ccr2 and uses thereof

Heiner Ebel; Sara Frattini; Kai Gerlach; Riccardo Giovannini; Christoph Hoenke; Marco Santagostino; Stefan Scheuerer; Thomas Trieselmann


Archive | 2006

Beta-agonists, processes for preparing them and their use as pharmaceutical compositions

Thomas Trieselmann; Bradford S. Hamilton; Dirk Stenkamp; Stephan Georg Mueller


Archive | 2008

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

Thomas Trieselmann; Bradford S. Hamilton


Archive | 2005

Novel beta agonists, method for producing the same and their use as drugs

Thomas Trieselmann; Bradford S. Hamilton

Collaboration


Dive into the Thomas Trieselmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge